Summary
Overview
Work History
Education
Skills
Certification
Technical Skills
Professional Memberships
Selected Published Work
Bibliography Link for complete list
Honors and Awards
Timeline
Generic

Hermela Shimelis, PhD

Summary

Determined and well-rounded individual with more than 10 years working as research scientist within healthcare industry. Sharp and focused professional offering skills in genetics and electronic health records data analysis.

Overview

17
17
years of professional experience
1
1
Certification

Work History

Staff Scientist

Geisinger
08.2018 - Current

Research projects:

  • Characterization of the impact of rare pathogenic variants on the neurodevelopmental and psychiatric outcomes of adults in a healthcare population
  • Identification of candidate genes for developmental brain disorders providing researchers a list of novel genes for further study by making data publicly available in the DBD Gene Database
  • Weight loss after surgical or medication treatment in patients with 16p11.2 deletion syndrome


Key Skills:

  • Whole exome sequence data analysis, genomic variant QC, variant classification following ACMG guidelines
  • Extraction of genetic and phenotypic data from linked genomic and electronic health record (EHR)
  • Statistical analysis: Logistic regression, Linear regression, mixed-linear model
  • Phenome Wide association analysis
  • New grant and annual progress report writing


Postdoctoral Research Fellow

Mayo Clinic
06.2013 - 06.2018

Research project:

  • Conducted molecular and genetic studies aimed at discovery of hereditary breast and ovarian cancer predisposition genes. Performed functional studies to determine clinical relevance of variants of uncertain significance in know breast and ovarian cancer predisposition genes.

Key skills:

  • Cell and molecular biology laboratory techniques
  • Genetic variant interpretation
  • Case-control study

Graduate Research Assistant

University of Maryland
08.2007 - 05.2013

Research Project:

  • Characterization of molecular signaling leading to the progression of prostate cancer.

Key skills:

  • Protein expression, purification and detection, SDS-PAGE, Western blotting, Co-immunoprecipitation, Chromatin immunoprecipitation, luciferase reporter assay, RNA isolation and purification, Quantitative real-time PCR (qRT-PCR), fluorescence microscopy, Mammalian cell culture techniques, transient transfection, Lentiviral infection, colorimetric assays of cell proliferation and cytotoxicity, colonogenic assays


Education

Ph.D. - Molecular Medicine

University of Maryland
Baltimore, MD
05.2013

Master of Science - Data Science, Healthcare Analytics

University of West Florida
Pensacola, FL
12.2025

B.S. - Biochemistry

George Mason University
Fairfax, VA
05.2006

Skills

  • Data analysis proficiency
  • Quantitative skills
  • Database Management
  • Experimental design
  • Bioinformatics Proficiency
  • Molecular Bench Work
  • Genomic Analysis
  • Research and publication
  • Grant writing experience
  • In-depth scientific knowledge
  • Team Leadership Qualities
  • Team Collaboration

Certification

  • Applied Data Science; MIT professional Education
  • Python for Data Science, AI and Development; IBM


Technical Skills

Programming Language : Python, R Programming, Shell Scripting

Database : My SQL, SQL server

Other Software/ Tools: Integrative Genomics Viewer, AlamutVisual, Prism

Professional Memberships

American Society of Human Genetics, 2018-Present

Selected Published Work

Early research projects focused on understanding molecular signaling leading to the progression of prostate cancer.  

Yang, X., Guo, Z., Sun, F., Li, W., Alfano, A., Shimelis, H., Chen, M., Brodie, A. M., Chen, H., Xiao, Z., et al. (2011). Novel membrane-associated androgen receptor splice variant potentiates proliferative and survival responses in prostate cancer cells. J Biol Chem 286, 36152-36160.

Xie, Y., Xu, K., Linn, D. E., Yang, X., Guo, Z., Shimelis, H., Nakanishi, T., Ross, D. D., Chen, H., Fazli, L., et al. (2008). The 44-kDa Pim-1 kinase phosphorylates BCRP/ABCG2 and thereby promotesits multimerization and drug-resistant activity in human prostate cancer cells. J Biol Chem 283, 3349-3356.

Xu, K., Shimelis, H., Linn, D. E., Jiang, R., Yang, X., Sun, F., Guo, Z., Chen, H., Li, W., Kong, X., et al. (2009). Regulation of androgen receptor transcriptional activity and specificity by RNF6-induced ubiquitination. Cancer Cell 15, 270-282.

Linn, D. E., Yang, X., Xie, Y., Alfano, A., Deshmukh, D., Wang, X., Shimelis, H., Chen, H., Li, W., Xu, K., et al. (2012). Differential regulation of androgen receptor by PIM-1 kinases via phosphorylation-dependent recruitment of distinct ubiquitin E3 ligases. J Biol Chem 287, 22959-22968.

Genetic studies that led to the identification of high- and moderate-risk breast cancer genes among those offered in multigene hereditary cancer panel testing.

Shimelis, H., Mesman, R. L. S., Von Nicolai, C.*, Ehlen, A.*, Guidugli, L., Martin, C., Calleja, F.,
Meeks, H., Hallberg, E., Hinton, J., et al. (2017). BRCA2 Hypomorphic Missense Variants Confer
Moderate Risks of Breast Cancer. Cancer Res 77, 2789-2799.

Couch, F. J., Shimelis, H., Hu, C.*, Hart, S. N., Polley, E. C., Na, J., Hallberg, E., Moore, R., Thomas, A., Lilyquist, J., et al. (2017). Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer. JAMA Oncol.

Guidugli, L., Shimelis, H. , Masica, D.L., Pankratz, V.S., Lipton, G., Singh, N., Hu, C., Monteiro, A.N., Lindor, N.M., Karchin, R. et al. (2017). Assessment of the clinical relevance of BRCA2 missense variants by functional and computational approaches. Am J Hum Genet

Shimelis, H., LaDuca, H., Hu, C., Hart, S. N., Na, J., Thomas, A., Akinhanmi, M., Moore, R., Brauch, H., Cox, A., Eccles., et al. (2018). Triple Negative Breast Cancer Risk Genes Identified by Multigene Hereditary Cancer Panel Testing. J. Natl. Cancer Inst. 110, 855–862

Hu, C., Hart, S.N., Polley, E.C., Gnanaolivu, R., Shimelis, H., Lee, K.Y., Lilyquist, J., Na, J., Moore, R., Antwi, S.O., et al. (2018). Association Between Inherited Germline Mutations in Cancer Predisposition Genes and Risk of Pancreatic Cancer. JAMA 319, 2401–2409.

Recent work on the characterization of the impact of rare pathogenic variants on the neurodevelopmental and psychiatric outcomes of adults.

Finucane, B., Savatt, J.M., Shimelis, H., Girirajan, S., and Myers, S.M. (2021). Birt-Hogg-Dubé symptoms in Smith-Magenis syndrome include pediatric-onset pneumothorax. Am. J. Med. Genet. A 185, 1922–1924.

Savatt, J.M., Shimelis, H., Moreno-De-Luca, A., Strande, N.T., Oetjens, M.T., Ledbetter, D.H., Martin, C.L., Myers, S.M., and Finucane, B.M. (2022). Frequency of truncating FLCN variants and Birt-Hogg-Dubé-associated phenotypes in a health care system population. Genet. Med. 10.1016/j.gim.2022.05.006.

Shimelis, H., Oetjens, M. T., Walsh, L. K., Wain, K. E., Znidarsic, M., Myers, S. M., Finucane, B. M., Ledbetter, D. H., & Martin, C. L. (2023). Prevalence and Penetrance of Rare Pathogenic Variants in Neurodevelopmental Psychiatric Genes in a Health Care System Population. The American Journal of Psychiatry, 180(1), 65–72.

Bibliography Link for complete list

https://www.ncbi.nlm.nih.gov/myncbi/1zmlJHjAK7m5Io/bibliography/public/

Honors and Awards

  • American Society of Human Genetics 2023 meeting Reviewers' Choice Abstract Award, 2023
  • American Society of Human Genetics 2021 meeting Reviewers' Choice Abstract Award, 2021,
  • Selected Member of Phi Kappa Phi Academic Honor Society, 2012,
  • Recipient of Department of Defense (DOD) FY09 Prostate Cancer training award Fellowship period June 2010-June 2013
  • Recipient of apprenticeship from Center for Teaching Excellence, George Mason University, 2005

Timeline

Staff Scientist

Geisinger
08.2018 - Current

Postdoctoral Research Fellow

Mayo Clinic
06.2013 - 06.2018

Graduate Research Assistant

University of Maryland
08.2007 - 05.2013

Ph.D. - Molecular Medicine

University of Maryland

Master of Science - Data Science, Healthcare Analytics

University of West Florida

B.S. - Biochemistry

George Mason University
Hermela Shimelis, PhD